Back to: products

Business Opportunities and Investment Strategies for Global Regenerative Medicine Market 2023-2033

PrintEmail
May 2024 | 186 Pages | From $1,000
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

 

Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global regenerative medicine market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the regenerative medicine industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global regenerative medicine industry.

Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global regenerative medicine market is expected to reach $117.43 billion by 2033, growing by 17.9% annually over the coming years.

Segmentation Analysis
Highlighted with 87 tables and 93 figures, this 186-page report represents a 360-degree view on the global market with extensively detailed segmentations by Therapy, Material, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Therapy
• Tissue-based Therapy
• Gene-based Therapy
• Cell-based Therapy
• Small Molecule & Biologic

By Material
• Synthetic Material
• Biologically Derived Material
• Genetically Engineered Material
• Other Materials

By Application
• Oncology
• Musculoskeletal
• Dermatology & Wound Care
• Immunology and Inflammation
• Cardiovascular Diseases
• Ophthalmology
• Other Applications

By End User
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Other End Users

By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Therapy, Application, and End User over the forecast years are also included.

Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• AbbVie Inc.
• Amgen, Inc.
• AstraZeneca plc
• Baxter International Inc.
• Bayer AG
• Becton Dickinson and Company
• Bristol-Myers Squibb Company
• Cook Biotech Inc.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline (GSK)
• Integra Lifesciences Corp.
• Medtronic PLC
• Merck KgaA
• Mimedx Group, Inc.
• Novartis AG
• Organogenesis Inc.
• Smith and Nephew plc
• Takeda Pharmaceutical Company Limited
• Thermo Fisher Scientific Inc.
• Vericel Corporation

Reasons to Purchase
• Gain a most comprehensive view on global market with lighting on market outlook, segmentations, dynamics and trends, growth opportunities, risk assessment, critical success factors (CSFs), increasingly attractive segments (IAS), and Porter’s Fiver Forces analysis.
• Access identified business opportunities and benchmarked investment strategies.
• Obtain up-to-date data and valuable insights to create regional and national strategies.
• Take wise actions to mitigate potential risk based on the matrix of systematic risk evaluation.
• Outperform competitors using the latest market data and research discoveries.
• Support internal and external presentations with reliable data and profound analysis.
• Backed up by premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
• Supported by free customer services before and after sales.

Table of Contents

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict 28
2.1.4 Impact of Israel-Palestine War 30
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 43
3 Segmentation of Global Market by Therapy 47
3.1 Market Overview by Therapy 47
3.2 Tissue-based Therapy 50
3.3 Gene-based Therapy 51
3.4 Cell-based Therapy 52
3.5 Small Molecule & Biologic 53
4 Segmentation of Global Market by Material 54
4.1 Market Overview by Material 54
4.2 Synthetic Material 57
4.3 Biologically Derived Material 58
4.4 Genetically Engineered Material 59
4.5 Other Materials 60
5 Segmentation of Global Market by Application 61
5.1 Market Overview by Application 61
5.2 Oncology 64
5.3 Musculoskeletal 65
5.4 Dermatology & Wound Care 66
5.5 Immunology and Inflammation 67
5.6 Cardiovascular Diseases 68
5.7 Ophthalmology 69
5.8 Other Applications 70
6 Segmentation of Global Market by End User 71
6.1 Market Overview by End User 71
6.2 Hospitals & Clinics 74
6.3 Ambulatory Surgical Centers 75
6.4 Other End Users 76
7 Segmentation of Global Market by Region 77
7.1 Geographic Market Overview 2023-2033 77
7.2 North America Market 2023-2033 by Country 82
7.2.1 Overview of North America Market 82
7.2.2 U.S. 86
7.2.3 Canada 89
7.2.4 Mexico 91
7.3 European Market 2023-2033 by Country 93
7.3.1 Overview of European Market 93
7.3.2 Germany 97
7.3.3 U.K. 99
7.3.4 France 101
7.3.5 Spain 103
7.3.6 Italy 105
7.3.7 Russia 107
7.3.8 Rest of European Market 109
7.4 Asia-Pacific Market 2023-2033 by Country 111
7.4.1 Overview of Asia-Pacific Market 111
7.4.2 Japan 115
7.4.3 China 118
7.4.4 Australia 120
7.4.5 India 122
7.4.6 South Korea 124
7.4.7 Rest of APAC Region 126
7.5 South America Market 2023-2033 by Country 128
7.5.1 Argentina 132
7.5.2 Brazil 134
7.5.3 Chile 136
7.5.4 Rest of South America Market 138
7.6 MEA Market 2023-2033 by Country 139
7.6.1 UAE 143
7.6.2 Saudi Arabia 145
7.6.3 South Africa 147
7.6.4 Other National Markets 149
8 Competitive Landscape 150
8.1 Overview of Key Vendors 150
8.2 New Product Launch, Partnership, Investment, and M&A 153
8.3 Company Profiles 154
AbbVie Inc. 154
Amgen, Inc. 156
AstraZeneca plc 157
Baxter International Inc. 158
Bayer AG 159
Becton Dickinson and Company 160
Bristol-Myers Squibb Company 161
Cook Biotech Inc. 162
F. Hoffmann La Roche Ltd. 163
Gilead Sciences, Inc. 164
GlaxoSmithKline (GSK) 165
Integra Lifesciences Corp. 166
Medtronic PLC 167
Merck KgaA 168
Mimedx Group, Inc. 169
Novartis AG 170
Organogenesis Inc. 171
Smith and Nephew plc 172
Takeda Pharmaceutical Company Limited 173
Thermo Fisher Scientific Inc. 174
Vericel Corporation 175
9 Investing in Regenerative Medicine Industry: Risk Assessment and Management 176
9.1 Risk Evaluation of Global Market 176
9.2 Critical Success Factors (CSFs) 183
RELATED REPORTS 186

List of Tables:

Table 1. Snapshot of Global Regenerative Medicine Market in Balanced Perspective, 2023-2033 19
Table 2. World Economic Outlook, 2024-2036 23
Table 3. World Economic Outlook, 2022-2024 25
Table 4. Scenarios for Economic Impact of Ukraine Crisis 29
Table 5. Scenarios for Economic Impact of Israel-Palestine War 30
Table 6. World Health Spending by Region, $ bn, 2013-2020 36
Table 7. Main Product Trends and Market Opportunities in Global Regenerative Medicine Market 40
Table 8. Global Regenerative Medicine Market by Therapy, 2023-2033, $ mn 48
Table 9. Global Regenerative Medicine Market by Material, 2023-2033, $ mn 55
Table 10. Global Regenerative Medicine Market by Application, 2023-2033, $ mn 62
Table 11. Global Regenerative Medicine Market by End User, 2023-2033, $ mn 72
Table 12. Global Regenerative Medicine Market by Region, 2023-2033, $ mn 79
Table 13. Leading National Regenerative Medicine Market, 2023 and 2033, $ mn 81
Table 14. North America Regenerative Medicine Market by Country, 2023-2033, $ mn 84
Table 15. U.S. Regenerative Medicine Market by Therapy, 2023-2033, $ mn 88
Table 16. U.S. Regenerative Medicine Market by Application, 2023-2033, $ mn 88
Table 17. U.S. Regenerative Medicine Market by End User, 2023-2033, $ mn 88
Table 18. Canada Regenerative Medicine Market by Therapy, 2023-2033, $ mn 90
Table 19. Canada Regenerative Medicine Market by Application, 2023-2033, $ mn 90
Table 20. Canada Regenerative Medicine Market by End User, 2023-2033, $ mn 90
Table 21. Mexico Regenerative Medicine Market by Therapy, 2023-2033, $ mn 92
Table 22. Mexico Regenerative Medicine Market by Application, 2023-2033, $ mn 92
Table 23. Mexico Regenerative Medicine Market by End User, 2023-2033, $ mn 92
Table 24. Europe Regenerative Medicine Market by Country, 2023-2033, $ mn 95
Table 25. Germany Regenerative Medicine Market by Therapy, 2023-2033, $ mn 98
Table 26. Germany Regenerative Medicine Market by Application, 2023-2033, $ mn 98
Table 27. Germany Regenerative Medicine Market by End User, 2023-2033, $ mn 98
Table 28. U.K. Regenerative Medicine Market by Therapy, 2023-2033, $ mn 100
Table 29. U.K. Regenerative Medicine Market by Application, 2023-2033, $ mn 100
Table 30. U.K. Regenerative Medicine Market by End User, 2023-2033, $ mn 100
Table 31. France Regenerative Medicine Market by Therapy, 2023-2033, $ mn 102
Table 32. France Regenerative Medicine Market by Application, 2023-2033, $ mn 102
Table 33. France Regenerative Medicine Market by End User, 2023-2033, $ mn 102
Table 34. Spain Regenerative Medicine Market by Therapy, 2023-2033, $ mn 104
Table 35. Spain Regenerative Medicine Market by Application, 2023-2033, $ mn 104
Table 36. Spain Regenerative Medicine Market by End User, 2023-2033, $ mn 104
Table 37. Italy Regenerative Medicine Market by Therapy, 2023-2033, $ mn 106
Table 38. Italy Regenerative Medicine Market by Application, 2023-2033, $ mn 106
Table 39. Italy Regenerative Medicine Market by End User, 2023-2033, $ mn 106
Table 40. Russia Regenerative Medicine Market by Therapy, 2023-2033, $ mn 108
Table 41. Russia Regenerative Medicine Market by Application, 2023-2033, $ mn 108
Table 42. Russia Regenerative Medicine Market by End User, 2023-2033, $ mn 108
Table 43. Regenerative Medicine Market in Rest of Europe by Country, 2023-2033, $ mn 110
Table 44. APAC Regenerative Medicine Market by Country, 2023-2033, $ mn 113
Table 45. Japan Regenerative Medicine Market by Therapy, 2023-2033, $ mn 117
Table 46. Japan Regenerative Medicine Market by Application, 2023-2033, $ mn 117
Table 47. Japan Regenerative Medicine Market by End User, 2023-2033, $ mn 117
Table 48. China Regenerative Medicine Market by Therapy, 2023-2033, $ mn 119
Table 49. China Regenerative Medicine Market by Application, 2023-2033, $ mn 119
Table 50. China Regenerative Medicine Market by End User, 2023-2033, $ mn 119
Table 51. Australia Regenerative Medicine Market by Therapy, 2023-2033, $ mn 121
Table 52. Australia Regenerative Medicine Market by Application, 2023-2033, $ mn 121
Table 53. Australia Regenerative Medicine Market by End User, 2023-2033, $ mn 121
Table 54. India Regenerative Medicine Market by Therapy, 2023-2033, $ mn 123
Table 55. India Regenerative Medicine Market by Application, 2023-2033, $ mn 123
Table 56. India Regenerative Medicine Market by End User, 2023-2033, $ mn 123
Table 57. South Korea Regenerative Medicine Market by Therapy, 2023-2033, $ mn 125
Table 58. South Korea Regenerative Medicine Market by Application, 2023-2033, $ mn 125
Table 59. South Korea Regenerative Medicine Market by End User, 2023-2033, $ mn 125
Table 60. Regenerative Medicine Market in Rest of APAC by Country/Region, 2023-2033, $ mn 127
Table 61. South America Regenerative Medicine Market by Country, 2023-2033, $ mn 130
Table 62. Argentina Regenerative Medicine Market by Therapy, 2023-2033, $ mn 133
Table 63. Argentina Regenerative Medicine Market by Application, 2023-2033, $ mn 133
Table 64. Argentina Regenerative Medicine Market by End User, 2023-2033, $ mn 133
Table 65. Brazil Regenerative Medicine Market by Therapy, 2023-2033, $ mn 135
Table 66. Brazil Regenerative Medicine Market by Application, 2023-2033, $ mn 135
Table 67. Brazil Regenerative Medicine Market by End User, 2023-2033, $ mn 135
Table 68. Chile Regenerative Medicine Market by Therapy, 2023-2033, $ mn 137
Table 69. Chile Regenerative Medicine Market by Application, 2023-2033, $ mn 137
Table 70. Chile Regenerative Medicine Market by End User, 2023-2033, $ mn 137
Table 71. MEA Regenerative Medicine Market by Country, 2023-2033, $ mn 141
Table 72. UAE Regenerative Medicine Market by Therapy, 2023-2033, $ mn 144
Table 73. UAE Regenerative Medicine Market by Application, 2023-2033, $ mn 144
Table 74. UAE Regenerative Medicine Market by End User, 2023-2033, $ mn 144
Table 75. Saudi Arabia Regenerative Medicine Market by Therapy, 2023-2033, $ mn 146
Table 76. Saudi Arabia Regenerative Medicine Market by Application, 2023-2033, $ mn 146
Table 77. Saudi Arabia Regenerative Medicine Market by End User, 2023-2033, $ mn 146
Table 78. South Africa Regenerative Medicine Market by Therapy, 2023-2033, $ mn 148
Table 79. South Africa Regenerative Medicine Market by Application, 2023-2033, $ mn 148
Table 80. South Africa Regenerative Medicine Market by End User, 2023-2033, $ mn 148
Table 81. AbbVie Inc.: Company Snapshot 154
Table 82. AbbVie Inc.: Business Segmentation 155
Table 83. AbbVie Inc.: Product Portfolio 155
Table 84. List of Risk Factors and Weight Percentages/Theoretical Maximum 177
Table 85. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL) 179
Table 86. Risk Evaluation for Investing in Global Market, 2023-2033 180
Table 87. Critical Success Factors and Key Takeaways 184

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 18
Figure 4. Global Regenerative Medicine Market, 2023-2033, $ mn 21
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of Global Regenerative Medicine Market 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 35
Figure 10. Primary Restraints and Impact Factors of Global Regenerative Medicine Market 37
Figure 11. Porter’s Fiver Forces Analysis of Global Regenerative Medicine Market 43
Figure 12. Growth Opportunity Analysis by Therapy 47
Figure 13. Breakdown of Global Regenerative Medicine Market by Therapy, 2023-2033, % of Revenue 48
Figure 14. Global Addressable Market Cap in 2024-2033 by Therapy, Value ($ mn) and Share (%) 49
Figure 15. Global Regenerative Medicine Market by Therapy: Tissue-based Therapy, 2023-2033, $ mn 50
Figure 16. Global Regenerative Medicine Market by Therapy: Gene-based Therapy, 2023-2033, $ mn 51
Figure 17. Global Regenerative Medicine Market by Therapy: Cell-based Therapy, 2023-2033, $ mn 52
Figure 18. Global Regenerative Medicine Market by Therapy: Small Molecule & Biologic, 2023-2033, $ mn 53
Figure 19. Growth Opportunity Analysis by Material 54
Figure 20. Breakdown of Global Regenerative Medicine Market by Material, 2023-2033, % of Sales Revenue 55
Figure 21. Global Addressable Market Cap in 2024-2033 by Material, Value ($ mn) and Share (%) 56
Figure 22. Global Regenerative Medicine Market by Material: Synthetic Material, 2023-2033, $ mn 57
Figure 23. Global Regenerative Medicine Market by Material: Biologically Derived Material, 2023-2033, $ mn 58
Figure 24. Global Regenerative Medicine Market by Material: Genetically Engineered Material, 2023-2033, $ mn 59
Figure 25. Global Regenerative Medicine Market by Material: Other Materials, 2023-2033, $ mn 60
Figure 26. Growth Opportunity Analysis by Application 61
Figure 27. Breakdown of Global Regenerative Medicine Market by Application, 2023-2033, % of Sales Revenue 62
Figure 28. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 63
Figure 29. Global Regenerative Medicine Market by Application: Oncology, 2023-2033, $ mn 64
Figure 30. Global Regenerative Medicine Market by Application: Musculoskeletal, 2023-2033, $ mn 65
Figure 31. Global Regenerative Medicine Market by Application: Dermatology & Wound Care, 2023-2033, $ mn 66
Figure 32. Global Regenerative Medicine Market by Application: Immunology and Inflammation, 2023-2033, $ mn 67
Figure 33. Global Regenerative Medicine Market by Application: Cardiovascular Diseases, 2023-2033, $ mn 68
Figure 34. Global Regenerative Medicine Market by Application: Ophthalmology, 2023-2033, $ mn 69
Figure 35. Global Regenerative Medicine Market by Application: Other Applications, 2023-2033, $ mn 70
Figure 36. Growth Opportunity Analysis by End User 71
Figure 37. Breakdown of Global Regenerative Medicine Market by End User, 2023-2033, % of Revenue 72
Figure 38. Global Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%) 73
Figure 39. Global Regenerative Medicine Market by End User: Hospitals & Clinics, 2023-2033, $ mn 74
Figure 40. Global Regenerative Medicine Market by End User: Ambulatory Surgical Centers, 2023-2033, $ mn 75
Figure 41. Global Regenerative Medicine Market by End User: Other End Users, 2023-2033, $ mn 76
Figure 42. Global Market Snapshot by Region 77
Figure 43. Growth Opportunity Analysis of Global Market by Region 78
Figure 44. Geographic Spread of Worldwide Regenerative Medicine Market, 2023-2033, % of Sales Revenue 79
Figure 45. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 80
Figure 46. North American Regenerative Medicine Market, 2023-2033, $ mn 83
Figure 47. Growth Opportunity Analysis of North America Market by Country 83
Figure 48. Breakdown of North America Regenerative Medicine Market by Country, 2023 and 2033, % of Revenue 84
Figure 49. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 85
Figure 50. U.S. Regenerative Medicine Market, 2023-2033, $ mn 87
Figure 51. Canada Regenerative Medicine Market, 2023-2033, $ mn 89
Figure 52. Regenerative Medicine Market in Mexico, 2023-2033, $ mn 91
Figure 53. European Regenerative Medicine Market, 2023-2033, $ mn 94
Figure 54. Growth Opportunity Analysis of Europe Market by Country 94
Figure 55. Breakdown of European Regenerative Medicine Market by Country, 2023 and 2033, % of Revenue 95
Figure 56. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57. Regenerative Medicine Market in Germany, 2023-2033, $ mn 97
Figure 58. Regenerative Medicine Market in U.K., 2023-2033, $ mn 99
Figure 59. Regenerative Medicine Market in France, 2023-2033, $ mn 101
Figure 60. Regenerative Medicine Market in Spain, 2023-2033, $ mn 103
Figure 61. Regenerative Medicine Market in Italy, 2023-2033, $ mn 105
Figure 62. Regenerative Medicine Market in Russia, 2023-2033, $ mn 107
Figure 63. Regenerative Medicine Market in Rest of Europe, 2023-2033, $ mn 109
Figure 64. Asia-Pacific Regenerative Medicine Market, 2023-2033, $ mn 112
Figure 65. Growth Opportunity Analysis of Asia-Pacific Market by Country 112
Figure 66. Breakdown of APAC Regenerative Medicine Market by Country, 2023 and 2033, % of Revenue 113
Figure 67. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 114
Figure 68. Regenerative Medicine Market in Japan, 2023-2033, $ mn 116
Figure 69. Regenerative Medicine Market in China, 2023-2033, $ mn 118
Figure 70. Regenerative Medicine Market in Australia, 2023-2033, $ mn 120
Figure 71. Regenerative Medicine Market in India, 2023-2033, $ mn 122
Figure 72. Regenerative Medicine Market in South Korea, 2023-2033, $ mn 124
Figure 73. Regenerative Medicine Market in Rest of APAC, 2023-2033, $ mn 126
Figure 74. South America Regenerative Medicine Market, 2023-2033, $ mn 129
Figure 75. Growth Opportunity Analysis of South America Market by Country 129
Figure 76. Breakdown of South America Regenerative Medicine Market by Country, 2023 and 2033, % of Revenue 130
Figure 77. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 131
Figure 78. Regenerative Medicine Market in Argentina, 2023-2033, $ mn 132
Figure 79. Regenerative Medicine Market in Brazil, 2023-2033, $ mn 134
Figure 80. Regenerative Medicine Market in Chile, 2023-2033, $ mn 136
Figure 81. Regenerative Medicine Market in Rest of South America, 2023-2033, $ mn 138
Figure 82. Regenerative Medicine Market in Middle East and Africa (MEA), 2023-2033, $ mn 140
Figure 83. Growth Opportunity Analysis of MEA Market by Country 140
Figure 84. Breakdown of MEA Regenerative Medicine Market by Country, 2023 and 2033, % of Revenue 141
Figure 85. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 142
Figure 86. Regenerative Medicine Market in UAE, 2023-2033, $ mn 143
Figure 87. Regenerative Medicine Market in Saudi Arabia, 2023-2033, $ mn 145
Figure 88. Regenerative Medicine Market in South Africa, 2023-2033, $ mn 147
Figure 89. Regenerative Medicine Market in the Rest of MEA, 2023-2033, $ mn 149
Figure 90. Growth Stage of Global Regenerative Medicine Industry over the Forecast Period 150
Figure 91. Comparison of Risk Factors by GMD RIN in 2023 180
Figure 92. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart 181
Figure 93. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart 181

Reviews

There are yet no reviews for this product.